Strategic Imperatives
Why Is It Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top Three Strategic Imperatives on the Global Drug Discovery and Early Development Outsourcing Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Market Overview and Dynamics - R&D Landscape
Pharmaceutical Market
Pharmaceutical Market - Top 20 Pharma Companies
Pharmaceutical Market - Global R&D Expenditure
Top 20 Pharma Companies' R&D Expenditure
Global Clinical Development Expenditure by Therapy Area
Global Drug Development Pipeline by Clinical Phase
Drug Development Pipeline by Clinical Phase - North America
Drug Development Pipeline by Clinical Phase - Europe
Venture Capital Landscape by Clinical Phase
M&A Landscape
M&A Landscape (continued)
M&A Landscape (continued)
Growth Opportunity Analysis
Scope of Analysis
Key Growth Metrics
Key Competitors
Key Services
Growth Drivers for the Drug Discovery and Early Development Outsourcing Market
Growth Restraints for the Drug Discovery and Early Development Outsourcing Market
Market Segmentation by Service Type
Revenue Forecast
Revenue Forecast by Service Type
Revenue Forecast Analysis
Revenue Forecast Analysis (continued)
Key Drivers by Region
Key Trends Analysis by Therapy
Key Trends Analysis by Service
Competitive Environment
Competitive Landscape
Key Participants' Capability Profile
Future Outlook for Key CROs
Future Outlook for Key CDMOs
Evolution of Drug Discovery and Early Development Value Chain
Growth Opportunity Universe
Growth Opportunity 1-AI in Early Drug Discovery (Lead Selection and Optimization)

Growth Opportunity 2-High-throughput Screening for RNA-targeting Small Molecule Therapy

Growth Opportunity 3-Ex vivo/In vivo Pharmacology Services in APAC

Growth Opportunity 4-Emerging Expression Platforms for Next-generation Biologics

Next Steps
Your Next Steps
Why Frost, Why Now?
List of Exhibits

Legal Disclaimer